Valuation: Neuland Laboratories Limited

Market Cap 280B 2.91B 2.6B 2.42B 2.2B 4.15B 4.18B 29.24B 11.38B 143B 10.93B 10.7B 460B P/E 2027 *
58.7x
P/E 2028 * 44.9x
Enterprise Value 283B 2.94B 2.62B 2.44B 2.22B 4.19B 4.22B 29.51B 11.48B 144B 11.03B 10.79B 464B EV / Sales 2027 *
11.6x
EV / Sales 2028 * 9.62x
Free-Float
62.26%
Yield 2027 *
0.11%
Yield 2028 * 0.14%
1 day-0.18%
1 week+1.97%
Current month+1.99%
1 month-4.61%
3 months+15.69%
6 months+64.96%
Current year+43.63%
1 week 20,730.3
Extreme 20730.3
21,955.05
1 month 20,730.3
Extreme 20730.3
24,235.05
Current year 11,500
Extreme 11500
24,235.05
1 year 11,500
Extreme 11500
24,235.05
3 years 3,612.05
Extreme 3612.05
24,235.05
5 years 965.85
Extreme 965.85
24,235.05
10 years 247.3
Extreme 247.3
24,235.05
Manager TitleAgeSince
Chief Executive Officer 47 2026-03-31
Director of Finance/CFO - 2022-11-22
Chief Tech/Sci/R&D Officer - 2023-02-28
Director TitleAgeSince
Director/Board Member 50 2001-12-31
Chairman 82 1984-01-06
Director/Board Member 47 2007-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+1.97%+43.94%+455.14% 2.91B
+0.02%-3.52%+36.11%+111.11% 1,019B
-1.21%-6.99%+34.08%+60.96% 610B
+1.12%-0.20%+13.62%+80.24% 470B
-3.30%-6.15%+56.45%+34.69% 344B
+1.76%+1.63%+23.09%+43.09% 336B
+1.64%-2.17%+11.81%+33.85% 266B
+2.68%-2.93%-5.20%+10.25% 241B
-0.01%-3.62%+35.28%+52.02% 218B
-0.08%-4.98%+28.34%+93.61% 179B
Average +0.76%-3.07%+27.75%+97.50% 368.57B
Weighted average by Cap. +0.86%-3.50%+28.74%+69.29%

Financials

2027 *2028 *
Net sales 24.43B 254M 226M 211M 192M 361M 364M 2.55B 991M 12.47B 952M 932M 40.09B 29.27B 304M 271M 253M 230M 433M 436M 3.05B 1.19B 14.94B 1.14B 1.12B 48.01B
Net income 4.8B 49.82M 44.45M 41.41M 37.68M 70.97M 71.49M 500M 195M 2.45B 187M 183M 7.87B 6.26B 65.05M 58.03M 54.06M 49.2M 92.65M 93.34M 653M 254M 3.2B 244M 239M 10.28B
Net Debt 2.56B 26.59M 23.72M 22.1M 20.11M 37.88M 38.16M 267M 104M 1.31B 99.83M 97.68M 4.2B 979M 10.17M 9.07M 8.45M 7.69M 14.48M 14.59M 102M 39.73M 500M 38.18M 37.35M 1.61B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
26-10-06 ₹21,817.45 -0.18% 3,158
26-10-05 ₹21,857.25 +1.68% 1,672
26-10-01 ₹21,496.30 +0.48% 4,152
26-09-30 ₹21,392.65 -0.01% 2,113
26-09-29 ₹21,395.85 -0.17% 29,374
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
21,857.25INR
Average target price
24,334.75INR
Spread / Average Target
+11.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock